Mechanism of action of foscarnet against viral polymerases
- PMID: 1371038
- DOI: 10.1016/0002-9343(92)90329-a
Mechanism of action of foscarnet against viral polymerases
Abstract
Foscarnet is a pyrophosphate analogue with activity against herpesviruses, human immunodeficiency virus (HIV), and other RNA and DNA viruses. Foscarnet and its analogues achieve their antiviral effects via inhibition of viral polymerases, with such inhibition not being dependent on activation or phosphorylation of the compounds by viral or cellular proteins. Current evidence indicates that foscarnet interferes with exchange of pyrophosphate from deoxynucleoside triphosphate during viral replication by binding to a site on the herpesvirus DNA polymerase or HIV reverse transcriptase. Reviewed herein are basic findings regarding the mechanism of action and antiviral activity of foscarnet and the related compound phosphonoacetic acid (PAA), as well as findings regarding potential mechanisms of viral resistance and interactions with other antiviral agents.
Similar articles
-
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).Pharmacol Ther. 1982;19(3):387-415. doi: 10.1016/0163-7258(82)90074-2. Pharmacol Ther. 1982. PMID: 6201932 Review. No abstract available.
-
Inhibition of HIV-1 RNA-dependent DNA polymerase and cellular DNA polymerases alpha, beta and gamma by phosphonoformic acid and other drugs.J Antimicrob Chemother. 1988 Feb;21(2):151-61. doi: 10.1093/jac/21.2.151. J Antimicrob Chemother. 1988. PMID: 2452149
-
Clinical pharmacology: foscarnet.Am J Med. 1992 Feb 14;92(2A):8S-11S. doi: 10.1016/0002-9343(92)90330-e. Am J Med. 1992. PMID: 1371039 Review.
-
Antiviral therapy targeting viral polymerase.Curr Pharm Des. 2006;12(11):1339-55. doi: 10.2174/138161206776361156. Curr Pharm Des. 2006. PMID: 16611119 Review.
-
Synergistic combinations and peptides in the inhibition of human immunodeficiency virus.Adv Enzyme Regul. 1991;31:85-97. doi: 10.1016/0065-2571(91)90010-j. Adv Enzyme Regul. 1991. PMID: 1715118
Cited by
-
KSHV targeted therapy: an update on inhibitors of viral lytic replication.Viruses. 2014 Nov 24;6(11):4731-59. doi: 10.3390/v6114731. Viruses. 2014. PMID: 25421895 Free PMC article. Review.
-
Efficacy of Antiviral Drugs against Feline Immunodeficiency Virus.Vet Sci. 2015 Dec 18;2(4):456-476. doi: 10.3390/vetsci2040456. Vet Sci. 2015. PMID: 29061953 Free PMC article. Review.
-
HCMV Antivirals and Strategies to Target the Latent Reservoir.Viruses. 2021 May 1;13(5):817. doi: 10.3390/v13050817. Viruses. 2021. PMID: 34062863 Free PMC article. Review.
-
Efficacy of antiviral chemotherapy for retrovirus-infected cats: What does the current literature tell us?J Feline Med Surg. 2015 Nov;17(11):925-39. doi: 10.1177/1098612X15610676. J Feline Med Surg. 2015. PMID: 26486979 Free PMC article. Review.
-
Characteristics of Helicase-Primase Inhibitor Amenamevir-Resistant Herpes Simplex Virus.Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0049421. doi: 10.1128/AAC.00494-21. Epub 2021 Jul 6. Antimicrob Agents Chemother. 2021. PMID: 34228537 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources